Cas Medical Systems Inc Revenue Growth Rates (CASM), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cas Medical Systems Inc  (CASM)
 

CASM's Revenue Growth by Quarter and Year

Cas Medical Systems Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CASM Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
4th Quarter December 5.80
3rd Quarter September 5.38
2nd Quarter June 5.29
1st Quarter March 5.44
FY 21.91

CASMs Annual Revenue
Cas Medical Systems Inc's Revenue in the fiscal year 2018 $ 21.92 millions
Cas Medical Systems Inc's Revenue in the fiscal year 2017 $ 18.76 millions
Cas Medical Systems Inc's Revenue in the fiscal year 2016 $ 22.24 millions
Cas Medical Systems Inc's Revenue in the fiscal year 2015 $ 21.64 millions
Cas Medical Systems Inc's Revenue in the fiscal year 2014 $ 22.91 millions




CASM Revenue fourth quarter 2018 Y/Y Growth Comment
Cas Medical Systems Inc achieved in the fourth quarter 2018, above Company average Revenue increase of 13.33% year on year, to $ 5.80 millions.

Looking into fourth quarter 2018 results within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue growth. While Cas Medical Systems Inc' s Revenue growth of 13.33% ranks overall at the positon no. 822 in the fourth quarter 2018.


CASM Revenue ( Y/Y Growth %) 2018
 2017 2016 2015
4th Quarter December 13.33 % -6.57 % -6.16 % 0.17 %
3rd Quarter September 18.76 % -8.67 % 0.2 % -10.49 %
2nd Quarter June 15.75 % -1.72 % -1.27 % -19.35 %
1st Quarter March 19.82 % -16.85 % 20.8 % -20.84 %
FY   16.8 % -8.71 % 2.65 % -

Financial Statements
Cas Medical Systems Inc's fourth quarter 2018 Revenue $ 5.80 millions CASM's Income Statement
Cas Medical Systems Inc's fourth quarter 2017 Revenue $ 5.12 millions Quarterly CASM's Income Statement


CASM Revenue (Quarter on Quarter Growth %)

 2018
 2017 2016 2015
4th Quarter December 7.85 % 13.02 % 10.48 % 17.98 %
3rd Quarter September 1.7 % -0.88 % 6.67 % 5.1 %
2nd Quarter June -2.76 % 0.66 % -14.84 % 4.2 %
1st Quarter March 6.25 % -17.15 % -6.51 % -22.47 %
FY (Year on Year)   16.8 % -8.71 % 2.65 % -


Back to CASM Growth rate Comparisons >> Back to CASM Growth rate Comparisons >>


Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #175
Overall #822

Revenue Y/Y Growth Statistics
High Average Low
30.68 % 0.08 % -21.44 %
(Dec 31 2018)   (Sep 30 2017)
Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #175
Overall #822
Revenue Y/Y Growth Statistics
High Average Low
30.68 % 0.08 % -21.44 %
(Dec 31 2018)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Cas Medical Systems Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
22.62 % 0.64 % -16.19 %
(Mar 31 2018)  


CASM's IV. Quarter Q/Q Revenue Comment
Cas Medical Systems Inc achieved in the IV. Quarter 2018 above company average sequential Revenue increase of 7.85%, to $ 5.80 millions, from $5.38 millions in the third quarter.

Within Medical Equipment & Supplies industry 57 other companies have achieved higher Revenue quarter on quarter growth. While Cas Medical Systems Inc's Revenue growth quarter on quarter, overall rank is 1268.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #58
Healthcare Sector #269
Overall #1268
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #58
Healthcare Sector #269
Overall #1268
Revenue Q/Q Growth Statistics
High Average Low
22.62 % 0.64 % -16.19 %
(Mar 31 2018)  


CASM's IV. Quarter Q/Q Revenue Comment
Cas Medical Systems Inc achieved in the IV. Quarter 2018 above company average sequential Revenue increase of 7.85%, to $ 5.80 millions, from $5.38 millions in the third quarter.

Within Medical Equipment & Supplies industry 57 other companies have achieved higher Revenue quarter on quarter growth. While Cas Medical Systems Inc's Revenue growth quarter on quarter, overall rank is 1268.


Cas Medical Systems Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2018)		 12 Months Ending
(Sep 30 2018)		 12 Months Ending
(Jun 30 2018)		 12 Months Ending
(Mar 31 2018)		 12 Months Ending
(Dec 31 2017)
Cumulative Revenue 12 Months Ending $ 21.92 $ 20.56 $ 19.70 $ 18.98 $ 18.08
Y / Y Revenue Growth (TTM) 21.23 % 7.5 % 0.74 % -3.32 % -12 %
Year on Year Revenue Growth Overall Ranking # 3547 # 467 # 1182 # 3259 # 1221
Seqeuential Revenue Change (TTM) 6.63 % 4.34 % 3.79 % 4.98 % -5.45 %
Seq. Revenue Growth (TTM) Overall Ranking # 3247 # 1131 # 1319 # 2393 # 863


Cumulative Revenue growth Comment
Cas Medical Systems Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 21.23% year on year, to $ 22 millions if the fiscal year would have ended in Dec 31 2018.
Cas Medical Systems Inc's trailing twelve months Revenue growth was higher than company's average -1.74% and higher than 7.5% growth in Sep 30 2018.
But from twelve months ended Sep 30 2018 rise was beneth at 6.63 % from $20.56 millions achieved in the period from Sep 30 2018 to Dec 31 2017.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -1.74%.
The momentum is even more impressive from twelve months ended Sep 30 2018 exhibited at 6.63 % increase from $20.56 millions in the period from Sep 30 2018 to Dec 31 2017.

In the Healthcare sector 429 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 467 to 3547.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 118
Healthcare Sector # 430
Overall # 3547

Revenue TTM Y/Y Growth Statistics
High Average Low
16.82 %
 -1.74 %
-15.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 118
Sector # 386
S&P 500 # 3247
Cumulative Revenue growth Comment
Cas Medical Systems Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 21.23% year on year, to $ 22 millions if the fiscal year would have ended in Dec 31 2018.
Cas Medical Systems Inc's trailing twelve months Revenue growth was higher than company's average -1.74% and higher than 7.5% growth in Sep 30 2018.
But from twelve months ended Sep 30 2018 rise was beneth at 6.63 % from $20.56 millions achieved in the period from Sep 30 2018 to Dec 31 2017.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -1.74%.
The momentum is even more impressive from twelve months ended Sep 30 2018 exhibited at 6.63 % increase from $20.56 millions in the period from Sep 30 2018 to Dec 31 2017.

In the Healthcare sector 429 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 467 to 3547.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 118
Healthcare Sector # 430
Overall # 3547

Revenue TTM Y/Y Growth Statistics
High Average Low
16.82 %
-1.74 %
-15.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 118
Sector # 386
S&P 500 # 3247




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CASM's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2018
Edap Tms Sa22.77%$ 22.769 millions
Applied Genetic Technologies Corporation22.30%$ 22.300 millions
Misonix Inc 22.26%$ 22.257 millions
Merit Medical Systems Inc22.19%$ 22.186 millions
Regeneron Pharmaceuticals Inc 21.82%$ 21.824 millions
Genmark Diagnostics Inc 20.95%$ 20.946 millions
Ani Pharmaceuticals Inc20.80%$ 20.801 millions
International Stem Cell Corporation20.68%$ 20.684 millions
Pacira Biosciences inc 20.28%$ 20.280 millions
Eagle Pharmaceuticals inc 19.81%$ 19.810 millions
Vanda Pharmaceuticals Inc 19.80%$ 19.796 millions
Organogenesis Holdings Inc 19.68%$ 19.677 millions
Genomic Health Inc19.60%$ 19.604 millions
Correvio Pharma Corp 19.44%$ 19.435 millions
Valeritas Holdings Inc.19.25%$ 19.253 millions
Incyte Corporation18.97%$ 18.968 millions
Fonar Corporation18.64%$ 18.638 millions
Intellia Therapeutics Inc 18.18%$ 18.176 millions
Ligand Pharmaceuticals Incorporated18.08%$ 18.082 millions
Revvity Inc17.88%$ 17.879 millions
Lifevantage Corp17.55%$ 17.552 millions
Intuitive Surgical Inc 17.27%$ 17.268 millions
Standard Biotools Inc 16.51%$ 16.507 millions
Celgene Corp15.91%$ 15.906 millions
Aspira Women s Health inc 15.54%$ 15.539 millions
Quidelortho Corp15.40%$ 15.404 millions
Celyad Oncology Sa15.33%$ 15.332 millions
Pro dex Inc 15.09%$ 15.090 millions
Innoviva Inc 14.87%$ 14.871 millions
Atricure Inc 14.83%$ 14.830 millions


About Cas Medical Systems Inc Revenue Growth Rates (CASM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.